Reprieve Cardiovascular
PrivateLast Round
Series B
Aug 13, 2025
Total Funding Raised
$171M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Reprieve Cardiovascular operates in Healthcare & Life Sciences and is based in Milford, Massachusetts. Its latest recorded funding round was a Series B round in August 2025.
Reprieve Cardiovascular is a medical device company that develops intelligent fluid management technologies for the treatment of acute decompensated heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reprieve Cardiovascular Comparables
Compare Reprieve Cardiovascular with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| WhiteSwell | 87% | |
| CardioRenal Systems | 83% | |
| Nuwe | 79% |
For institutional investors. Book with your work email.
Reprieve Cardiovascular Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 13, 2025 | ||||
| Series B | Aug 13, 2024 | ||||
| Series A | Feb 20, 2024 | ||||
| Seed | Sep 18, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Reprieve Cardiovascular Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series A, Series B |
| Arboretum Ventures | Series A, Series B |
| Lightstone Ventures | Series B, Series A |
| Cadence Healthcare Ventures | Series B |
| Santé Ventures | Series B, Series A |
| Genesis Capital | Series B, Series A |
| Cadence Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
Grew 16% QoQ, from 32 to 37 employees.
- Aug 13, 2024
$61M round completed.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 29, 2026
Reprieve Cardiovascular, LLC is developing a system to personalize fluid removal for patients with acute decompensated heart failure, with clinical collaboration and strategic guidance from UNC Health.
For institutional investors. Book with your work email.
Reprieve Cardiovascular Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Reprieve Cardiovascular's valuation, stock price, and market status.
Is Reprieve Cardiovascular a public or private company?
Reprieve Cardiovascular is a private company.
What is the current stock price of Reprieve Cardiovascular?
Reprieve Cardiovascular is a private company, so its shares have no public market price. Caplight tracks Reprieve Cardiovascular's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reprieve Cardiovascular worth (valuation)?
Valuation information for Reprieve Cardiovascular is not publicly available.
Can I buy Reprieve Cardiovascular stock?
Reprieve Cardiovascular shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reprieve Cardiovascular's last funding round?
Reprieve Cardiovascular's most recent funding round was Series B on August 13, 2025.
Who are the main investors in Reprieve Cardiovascular?
Key investors in Reprieve Cardiovascular include Deerfield Management, Lightstone Ventures, Santé Ventures, Genesis Capital, Sante.
Will Reprieve Cardiovascular IPO soon?
No public IPO plans have been announced for Reprieve Cardiovascular.
How can I track Reprieve Cardiovascular secondary market activity?
Caplight tracks bids, offers, and trades in Reprieve Cardiovascular's shares on secondary markets.